CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)


Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL


Become EABM
Become Reviewer

Commentary promotion: free to download

Volume:9   Issue: 6
Pp: 667-667
Oscar Arias-Carrion and Maria Stamelou
DOI: 10.2174/187152710793237467

Editorial [Hot Topic: Drug Discovery for CNS Disorders: From Bench to Bedside (Guest Editor: Tiago Fleming Outeiro)] promotion: free to download

Volume:9   Issue: 6
Pp: 668-668
Aleksey G. Kazantsev and Tiago Fleming Outeiro
DOI: 10.2174/187152710793237395

Development of Novel Genomic Blood Biomarkers for Neurodegenerative Diseases

Volume:9   Issue: 6
Pp: 669-678
Fran Borovecki and Mario Habek
DOI: 10.2174/187152710793237476

Organelle Stress Sensors and Cell Death Mechanisms in Neurodegenerative Diseases

Volume:9   Issue: 6
Pp: 679-692
Ricardo J.S. Viana, Maria B. Fonseca, Rita M. Ramalho, Ana F. Nunes and Cecilia M.P. Rodrigues
DOI: 10.2174/187152710793237511

Phenotypic Screening Strategies for Neurodegenerative Diseases: A Pathway to Discover Novel Drug Candidates and Potential Disease Targets or Mechanisms open access plus

Volume:9   Issue: 6
Pp: 693-700
R. M. Pruss
DOI: 10.2174/187152710793237377

Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders

Volume:9   Issue: 6
Pp: 701-719
Maria Xilouri and Leonidas Stefanis
DOI: 10.2174/187152710793237421

Wnt Signalling is a Relevant Pathway Contributing to Amyloid Beta-Peptide-Mediated Neuropathology in Alzheimers Disease

Volume:9   Issue: 6
Pp: 720-726
Odete A.B. da Cruz e Silva, Ana Gabriela Henriques, Sara Catarina Timoteo Santos Domingues and Edgar F. da Cruz e Silva
DOI: 10.2174/187152710793237458

Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies

Volume:9   Issue: 6
Pp: 727-740
Nahuai Badiola, Marc Suarez-Calvet and Alberto Lleo
DOI: 10.2174/187152710793237403

Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics

Volume:9   Issue: 6
Pp: 741-753
S. K. Kalia, L. V. Kalia and P. J. McLean
DOI: 10.2174/187152710793237386

Neurotrophic Factors as a Protective Strategy in Parkinsons Disease

Volume:9   Issue: 6
Pp: 754-763
Maria Jose Diogenes and Tiago Fleming Outeiro
DOI: 10.2174/187152710793237449

Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis

Volume:9   Issue: 6
Pp: 764-778
Julia Costa, Catarina Gomes and Mamede de Carvalho
DOI: 10.2174/187152710793237502

Genetic Determinants of Amyotrophic Lateral Sclerosis as Therapeutic Targets

Volume:9   Issue: 6
Pp: 779-790
Daryl A. Bosco and John E. Landers
DOI: 10.2174/187152710793237494

Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease

Volume:9   Issue: 6
Pp: 791-800
Mathuravani A. Thevandavakkam, Robert Schwarcz, Paul J. Muchowski and Flaviano Giorgini
DOI: 10.2174/187152710793237430

Schwann Cells as a Therapeutic Target for Peripheral Neuropathies

Volume:9   Issue: 6
Pp: 801-806
Helmar C. Lehmann and Ahmet Hoke
DOI: 10.2174/187152710793237412

Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?

Volume:9   Issue: 6
Pp: 807-812
Daniele De Filippis, Mariateresa Cipriano, Giuseppe Esposito, Caterina Scuderi, Luca Steardo and Teresa Iuvone
DOI: 10.2174/187152710793237485